Lymphocyte Function in Autism and Rett Syndrome
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Peripheral blood lymphocytes from 17 patients with autism were separated on a Ficoll-Hypaque density gradient. Patients had normal numbers of T and B cells and T cell subsets. Although CD4:CD8 ratios were normal for the whole group (2.09 +/- 0.97), 6 patients had elevated ratios (> 2.2) and 5 had decreased ratios (< 1.5). Mitogen-induced proliferation (concanavalin-A and phytohemagglutinin) was normal as was the autologous mixed lymphocyte reaction for the whole group. There was an abnormally increased percentage of DR+ (activated) T lymphocytes in 11 patients. With increasing age percentage of DR+ lymphocytes decreased. No patient had interleukin-2 (IL-2) receptor+ cells. Similar investigations performed on blood samples from 8 girls with Rett syndrome produced normal results. 11 of 17 autistic patients had an abnormally increased percentage of DR+ but not IL-2 receptor+ lymphocytes suggesting 'incomplete' activation, a finding which is seen in autoimmune diseases. The decrease in activated cells with increasing age suggests that there may be an autoimmune process which is more active earlier in life in a subset of autistics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T-cell skewing to a TH2 phenotype (which is considered ‘anti-inflammatory’ and found in a subset of the ASD population) has been associated with better cognitive and adaptive behaviour126,131, but in another study, elevated levels of the classic TH2 cytokine IL-4 have been associated with greater impairments in non-verbal communication119.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [131]
In the citing paper
“Full immune system reconstitution from control animals also rescues peripheral immune abnormalities in MIA offspring, including deficits in regulatory T-cells and a disproportionate increase in CD4+ memory T cells with an inflammatory profile previously implicated in learning and memory deficits131,132”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [131]
Citations
Cites
Isolation of mononuclear cells and granulocytes from human blood.
Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 9,585
Hagberg, B., Aicardi, J., Dias, K., & Ramos, O. (1983) · Annals of Neurology · doi:10.1002/ana.410140412 · Cited by 1,514
Selective Loss of the Suppressor-Inducer T-Cell Subset in Progressive Multiple Sclerosis
Morimoto, C., Hafler, D. A., Weiner, H. L., Letvin, N. L., Hagan, M., Daley, J., & Schlossman, S. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701083160202 · Cited by 240
Immune abnormalities in patients with autism
Warren, R. P., Margaretten, N. C., Pace, N. C., & Foster, A. (1986) · Journal of Autism and Developmental Disorders · doi:10.1007/bf01531729 · Cited by 207
Depressed lymphocyte responsiveness in autistic children
Stubbs, E. G., Crawford, M. L., Burger, D. R., & Vandenbark, A. A. (1977) · Journal of Autism and Childhood Schizophrenia · doi:10.1007/bf01531114 · Cited by 202
Reduced Natural Killer Cell Activity in Autism
WARREN, R. P., FOSTER, A., & MARGARETTEN, N. C. (1987) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198705000-00008 · Cited by 190
Abnormal immune response to brain tissue antigen in the syndrome of autism
(1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.11.1462 · Cited by 136
Immunodiagnosis and Immunotherapy in Autistic Childrena
Singh, V. K., Fudenberg, H. H., EMERSON, D., & Coleman, M. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb27186.x · Cited by 56
ROLE OF VIRAL INFECTION AND AUTOIMMUNITY IN ÆTIOLOGY AND PATHOGENESIS OF MULTIPLE SCLEROSIS
Field, E. J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91542-0 · Cited by 17
Synovial fluid lymphocytes in different subtypes of juvenile rheumatoid arthritis
Bergroth, V., Konttinen, Y. T., Pelkonen, P., Haapala, M., Haapasaari, J., Nordström, D., Kunnamo, I., & Friman, C. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310613 · Cited by 16
Cited by
Immune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514
The immune response in autism: a new frontier for autism research
Ashwood, P., Wills, S., & Van de Water, J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1205707 · Cited by 528
“Immune aberrations consistent with a dysregulated immune response reported in autistic children include decreased peripheral lymphocyte numbers [30], decreased response to T 2 Journal of Leukocyte Biology Volume 80, July 2006 http://www.jleukbio.org cell mitogens [26, 27], incomplete or partial T cell activation evinc…”
BackgroundInfluentialFamilial Clustering of Autoimmune Disorders and Evaluation of Medical Risk Factors in Autism
Comi, A. M., Zimmerman, A. W., Frye, V. H., Law, P. A., & Peeden, J. N. (1999) · Journal of Child Neurology · doi:10.1177/088307389901400608 · Cited by 387
Modeling an autism risk factor in mice leads to permanent immune dysregulation
Hsiao, E. Y., McBride, S. W., Chow, J., Mazmanian, S. K., & Patterson, P. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202556109 · Cited by 340
“Increases in activated DR T cells are observed in human autism (29, 30).”
BackgroundActivation of the Inflammatory Response System in Autism
Croonenberghs, J., Bosmans, E., Deboutte, D., Kenis, G., & Maes, M. (2002) · Neuropsychobiology · doi:10.1159/000048665 · Cited by 322
Altered T cell responses in children with autism
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.09.002 · Cited by 281
“This profile may suggest an altered activation of T cells in ASD and is consistent with previous findings of reduced frequency of CD25 expressing T cells, but not HLA-DR expressing T cells, in ASD (Denney et al., 1996; Plioplys et al., 1994; Mostafa et al., 2010).”
BackgroundResultCirculating autoantibodies to neuronal and glial filament proteins in autism
Singh, V. K., Warren, R., Averett, R., & Ghaziuddin, M. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00045-3 · Cited by 234
Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism
Martin, L. A., Ashwood, P., Braunschweig, D., Cabanlit, M., Van de Water, J., & Amaral, D. G. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.007 · Cited by 231
“, 1997), cerebellar neurofilaments (Plioplys et al., 1994), and a-2-adrenergic binding sites (Cook et al.”
Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism
Singh, V. K. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00014-8 · Cited by 199
“Recently, DR+ activated T cells were also shown to be increased in autistic patients (Plioplys et al., 1994; Warren et al., 1995).”
BackgroundNovel treatments for autistic spectrum disorders
Levy, S. E., & Hyman, S. L. (2005) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20062 · Cited by 171
High nitric oxide production in autistic disorder: a possible role for interferon-γ
Sweeten, T. L., Posey, D. J., Shankar, S., & McDougle, C. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.001 · Cited by 172
Wills, S., Cabanlit, M., Bennett, J., Ashwood, P., Amaral, D. G., & Van de Water, J. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.007 · Cited by 163
“…shock protein as well as autoantibodies directed against epitopes within the cerebellum (Cabanlit et al., 2007; Connolly et al., 1999; Evers et al., 2002; Plioplys et al., 1994; Silva et al., 2004; Singer et al., 2006; Singh et al., 1998, 1997a,b, 1993; Todd et al., 1988; Vojdani et al., 2002).”
BackgroundHigh Blood Monocyte Counts and Neopterin Levels in Children With Autistic Disorder
Sweeten, T. L., Posey, D. J., & McDougle, C. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1691 · Cited by 151
“Furthermore, evidence of immune system activation, including an abnormal CD4:CD8 T cell ratio (1), a high number of DR+ (activated) T cells (4), high urinary neopterin levels (5, 6), and high cytokine production (7, 8), has been reported.”
BackgroundBrain‐Specific Autoantibodies in the Plasma of Subjects with Autistic Spectrum Disorder
CABANLIT, M., WILLS, S., GOINES, P., ASHWOOD, P., & VAN DE WATER, J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1381.010 · Cited by 157
Antibodies against fetal brain in sera of mothers with autistic children
Singer, H. S., Morris, C. M., Gause, C. D., Gillin, P. K., Crawford, S., & Zimmerman, A. W. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.004 · Cited by 152
“, 2005), evidence of immune dysregulation (Gupta, 2000), and abnormal levels of plasma immunoglobulins (Plioplys et al., 1994).”
BackgroundIn Search of Cellular Immunophenotypes in the Blood of Children with Autism
Ashwood, P., Corbett, B. A., Kantor, A., Schulman, H., Van de Water, J., & Amaral, D. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019299 · Cited by 140
“Previous reports have demonstrated differences in lymphocyte populations in autism, including increased numbers of NK cells [14] and reduced numbers of T cells [10,19,20,46,47] or altered activation status of T cell subsets [8,21].”
ResultIncreased serum albumin, γ globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism
CROONENBERGHS, J., WAUTERS, A., DEVREESE, K., VERKERK, R., SCHARPE, S., BOSMANS, E., EGYED, B., DEBOUTTE, D., & MAES, M. (2002) · Psychological Medicine · doi:10.1017/s0033291702006037 · Cited by 128
“…a lowered CD4+}CD8+ ratio, reduced natural killer cell (NKC) cytotoxicity, a lower percentage of lymphocytes expressing the interleukin-2 receptor (IL-2R) (Warren et al. 1987, 1990; Denney et al. 1996) and incomplete or partial T- 1457 cell activation (Plioplys et al. 1994; Warren et al. 1995).”
BackgroundGenetic and Immunologic Considerations in Autism
Korvatska, E., Van de Water, J., Anders, T. F., & Gershwin, M. E. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0479 · Cited by 127
Antibrain antibodies in children with autism and their unaffected siblings
Singer, H. S., Morris, C. M., Williams, P. N., Yoon, D. Y., Hong, J. J., & Zimmerman, A. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.025 · Cited by 132
“, 2005), evidence of immune dysregulation (Gupta, 2000) and abnormal levels of plasma immunoglobulins (Plioplys et al., 1994).”
BackgroundStrong association of the third hypervariable region of HLA-DRβ1 with autism
Warren, R. P., Odell, J. D., Warren, W. L., Burger, R. A., Maciulis, A., Daniels, W. W., & Torres, A. R. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00052-5 · Cited by 130
“, activated T cells (Plioplys et al., 1994b; Warren et al., 1995a) and depressed natural killer cell function (Warren et al., 1987).”
BackgroundA Review of Autism and the Immune Response
Ashwood, P., & Van de Water, J. (2004) · Journal of Immunology Research · doi:10.1080/10446670410001722096 · Cited by 123
“, 1986), incomplete or partial T cell activation evinced by increased numbers of DRþT cells without the expression of the IL-2 receptor (Plioplys et al., 1994; Denney et al., 1996), dysregulated apoptosis mechanisms (Engstrom et al.”
BackgroundInfluentialAbnormal Measles-Mumps-Rubella Antibodies and CNS Autoimmunity in Children with Autism
Singh, V. K., Lin, S.-R. X., Newell, E., & Nelson, C. (2002) · Journal of Biomedical Sciences · doi:10.1159/000065007 · Cited by 122
Macrophage migration inhibitory factor and autism spectrum disorders
Grigorenko, E. L., Han, S. S., Yrigollen, C. M., Leng, L., Mizue, Y., Anderson, G. M., Mulder, E. J., de Bildt, A., Minderaa, R. B., Volkmar, F. R., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3604 · Cited by 118
Confirmation of the association of the C4B null allelle in autism
Odell, D., Maciulis, A., Cutler, A., Warren, L., McMahon, W. M., Coon, H., Stubbs, G., Henley, K., & Torres, A. (2005) · Human Immunology · doi:10.1016/j.humimm.2004.11.002 · Cited by 110
Intravenous Immunoglobulin Treatment of Children With Autism
Plioplys, A. V. (1998) · Journal of Child Neurology · doi:10.1177/088307389801300207 · Cited by 93
Self-citationEffectiveness of N,N-Dimethylglycine in Autism and Pervasive Developmental Disorder
Kern, J. K., Miller, V. S., Cauller, L., Kendall, R., Mehta, J., & Dodd, M. (2001) · Journal of Child Neurology · doi:10.1177/088307380101600303 · Cited by 86
Hornig, M., & Lipkin, W. I. (2001) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1028 · Cited by 89
Saresella, M., Marventano, I., Guerini, F. R., Mancuso, R., Ceresa, L., Zanzottera, M., Rusconi, B., Maggioni, E., Tinelli, C., & Clerici, M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.020 · Cited by 112
Balmer, D., Arredondo, J., Samaco, R. C., & LaSalle, J. M. (2002) · Human Genetics · doi:10.1007/s00439-002-0724-4 · Cited by 70
“As abnormalities in the immune system are not apparent in RTT patients ( Plioplys et al. 1994 ), the adverse effect of MECP2mutations on the in vitro growth of lymphocytes are not expected to significantly impact the immune response in vivo.”
Brief Report: Immune Factors in Autism: A Critical Review
Krause, I., He, X.-S., Gershwin, M. E., & Shoenfeld, Y. (2002) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1016391121003 · Cited by 80
“In contrast, others have reported normal numbers of T and B cells and T-cell subsets in children with autistic disorder, as well as a normal response to mitogens, but found abnormal (both elevated and decreased) CD4fiCD8 ratios ( Plioplys, Greaves, Kazemi, & Silverman, 1994 ).”
ResultInfection in the First 2 Years of Life and Autism Spectrum Disorders
Rosen, N. J., Yoshida, C. K., & Croen, L. A. (2007) · Pediatrics · doi:10.1542/peds.2006-1788 · Cited by 76
Phenotypic expression of Autoimmune Autistic Disorder (Aad): A Major subset of Autism
Singh, V. K. (2009) · Annals of Clinical Psychiatry · doi:10.1177/104012370902100303 · Cited by 73
“35,36 Thus, it is reasonable to conclude that the increase of IL-12 in autistic children points to antigenic stimulation of Th1 cells that, via INF-γ , may induce autoimmunity.”
Microglia as a critical player in both developmental and late-life CNS pathologies
Derecki, N. C., Katzmarski, N., Kipnis, J., & Meyer-Luehmann, M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1321-z · Cited by 78
Autoantibody repertoires to brain tissue in autism nuclear families
Silva, S. C., Correia, C., Fesel, C., Barreto, M., Coutinho, A. M., Marques, C., Miguel, T. S., Ataide, A., Bento, C., Borges, L., et al. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.03.015 · Cited by 76
“Abnormal levels of immunoglobulins in plasma or cerebro-spinal fluid of patients have been reported in some studies, but are not corroborated by others (Plioplys et al., 1994).”
ResultLeoncini, S., De Felice, C., Signorini, C., Zollo, G., Cortelazzo, A., Durand, T., Galano, J.-M., Guerranti, R., Rossi, M., Ciccoli, L., et al. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/421624 · Cited by 71
“Cytokine Dysregulation in MECP2- and CDKL5-Related Rett”
Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome
Shenoy, S. M., Arnold, S., & Chatila, T. A. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.105355 · Cited by 66
“8 CD3/CD8 (%) [15-42] 20 CD3/CD4-CD8- (%) 13.”
Chez, M. G., Lepage, C., Parise, C. A., Dang-Chu, A., Hankins, A. I., & Carroll, M. P. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0042 · Cited by 75
The major histocompatibility complex and autism spectrum disorder
Needleman, L. A., & McAllister, A. K. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22046 · Cited by 66
“In addition, abnormalities in peripheral immune cells correlate with behavioral symptoms in ASD (Plioplys et al., 1994; Enstrom et al., 2009, 2010) and signs of neural inflammation are present in the brains of postmortem individuals with ASD (Vargas et al.”
BackgroundTheoretical aspects of autism: biomarkers—a review
Ratajczak, H. V. (2011) · Journal of Immunotoxicology · doi:10.3109/1547691x.2010.538749 · Cited by 57
“Alternately, DR activated T-lymphocytes were increased in blood of autistic patients in contrast to normal IL-2 receptors on lymphocytes, suggesting incomplete activation of the cells, often seen in autoimmune disease (Plioplys et al., 1994).”
BackgroundDecreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders
Onore, C., Enstrom, A., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., de Water, J. V., & Ashwood, P. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.09.005 · Cited by 67
“Previously, partial/incomplete or hypoactive T cell responses have been demonstrated in autism individuals following activation (Warren et al., 1986; Plioplys et al., 1994; Denney et al., 1996), Neurogenesis is influenced by the interaction between T cells and CNS-microglia cells, whereby too little or too much immune…”
Hyperserotoninemia and Altered Immunity in Autism
Burgess, N. K., Sweeten, T. L., McMahon, W. M., & Fujinami, R. S. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0100-7 · Cited by 69
Autism and immune factors: A comprehensive review
Stigler, K. A., Sweeten, T. L., Posey, D. J., & McDougle, C. J. (2009) · Research in Autism · doi:10.1016/j.rasd.2009.01.007 · Cited by 70
Rett syndrome and other autism spectrum disorders—brain diseases of immune malfunction?
Derecki, N. C., Privman, E., & Kipnis, J. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.21 · Cited by 50
The association of MHC genes with autism
Torres, A. (2001) · Frontiers in Bioscience · doi:10.2741/torres · Cited by 48
Edelson, S. B., & Cantor, D. S. (1998) · Toxicology and Industrial Health · doi:10.1177/074823379801400406 · Cited by 46
Compromised immune/inflammatory responses in Rett syndrome
Pecorelli, A., Cervellati, C., Cordone, V., Hayek, J., & Valacchi, G. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.023 · Cited by 60
Freeman, S. J., Roberts, W., & Daneman, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.925 · Cited by 47
Jones, K. L., Will, M. J., Hecht, P. M., Parker, C. L., & Beversdorf, D. Q. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.10.028 · Cited by 49
Intestinal cytokines in children with pervasive developmental disorders
DeFelice, M. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00444-1 · Cited by 48
“A number of immune system abnormalities have been described in children with autism, including IgA deficiency (18), decreased numbers of CD4 T cells, and natural killer cells (19, 20), increased numbers of activated T cells (21), and aberrant cell-mediated and antibody responses to myelin basic protein and neurofilame…”
BackgroundBiogenic Amines in Rett Syndrome: The Usual Suspects
Roux, J., & Villard, L. (2009) · Behavior Genetics · doi:10.1007/s10519-009-9303-y · Cited by 45
“Analysis performed on blood, plasma and serum samples from RTT patients revealed either inconsistent abnormalities or no abnormalities (Riederer et al. 1985; Plioplys et al. 1994; Fiumara et al. 1999).”
BackgroundPierce, K., Glatt, S. J., Liptak, G. S., & McIntyre, L. L. (2009) · Annals of Clinical Psychiatry · doi:10.1177/104012370902100302 · Cited by 36
Autism Spectrum Disorders: From Immunity to Behavior
Careaga, M., & Ashwood, P. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-62703-071-7_12 · Cited by 38
Dialysable lymphocyte extract (DLyE) in infantile onset autism: A pilot study
Fudenberg, H. H. (1996) · Biotherapy · doi:10.1007/bf02628672 · Cited by 45
Trajkovski, V., Петличковски, А., Ефинска-Младеновска, О., Трајков, Д., Arsov, T., Strezova, A., Ajdinski, L., & Spiroski, M. Z. (2008) · Focus on Autism and Other Developmental Disabilities · doi:10.1177/1088357608320413 · Cited by 37
Prandota, J. (2010) · Research in Autism · doi:10.1016/j.rasd.2010.03.009 · Cited by 35
Peripheral lymphocyte subsets and other immune aspects in Rett syndrome.
Fiumara, A., Sciotto, A., Barone, R., D’Asero, G., Munda, S., Parano, E., & Pavone, L. (1999) · Pediatric Neurology · doi:10.1016/s0887-8994(99)00053-3 · Cited by 34
“The few studies on RS furnish different results [5-7].”
ResultKronfol, Z. (2003) · Neurobiological Foundation of Aberrant Behaviors · doi:10.1007/978-1-4615-0323-1 · Cited by 31
Characterization of Immune Cell Phenotypes in Adults with Autism Spectrum Disorders
López-Cacho, J. M., Gallardo, S., de la Paz, M. P., Aguerri, M., Calzada, D., Mayayo, T., Lahoz, C., & Cárdaba, B. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000070 · Cited by 33
Heuer, L. S., Rose, M., Ashwood, P., & Van de Water, J. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.001 · Cited by 28
“, 1996), decreased proliferative response to mitogen challenge (Stubbs and Crawford, 1977), altered activation states in the periphery (Ashwood et al., 2011; Plioplys et al., 1994; Warren et al., 1995), and altered cytokine profiles (Gupta et al.”
BackgroundImmunological Aetiology of Major Psychiatric Disorders: Evidence and Therapeutic Implications
Sperner‐Unterweger, B. (2005) · Drugs · doi:10.2165/00003495-200565110-00004 · Cited by 99
Neuro-immunopathogenesis in autism
Singh, V. K. (2001) · Neuroimmune biology · doi:10.1016/s1567-7443(01)80041-7 · Cited by 20
Decreased Expression of CD95 (FAS/APO-1) on CD4+ T-lymphocytes from Participants with Autism
Engström, H. A., Ohlson, S., Stubbs, E. G., Maciulis, A., Caldwell, V. D., Odell, J. D., & Torres, A. R. (2003) · Journal of Developmental and Physical Disabilities · doi:10.1023/a:1022827417414 · Cited by 23
Immune function in autistic children
Stern, L., Francoeur, M., Primeau, M.-N., Somerville, W., Fombonne, E. J., & Mazer, B. D. (2005) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61019-8 · Cited by 29
McLellan, J., Kim, D. H. J., Bruce, M. R., Ramirez-Celis, A., & de Water, J. V. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.834910 · Cited by 38
Intra-monocyte pathogens delineate autism subgroups
Binstock, T. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1247 · Cited by 40
Modeling the role of infections in the etiology of mental illness
Pearce, B. D. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00098-7 · Cited by 22
Gonçalez, J. L., Shen, J., & Li, W. (2024) · Cells · doi:10.3390/cells13242077 · Cited by 23
Bailey, A. R., Hou, H., Obregon, D. F., Tian, J., Zhu, Y., Zou, Q., Nikolic, W. V., Bengtson, M. A., Mori, T., Murphy, T. K., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-195438 · Cited by 25
Immunotherapy for brain diseases and mental illnesses
Singh, V. K. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8861-5_5 · Cited by 19
Maternal infection and white matter toxicity
Harry, G. J., Lawler, C. P., & Brunssen, S. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.05.004 · Cited by 17
“With regard to autoimmune responses, patient-derived activated T cells (Plioplys et al., 1994) and lymphocytes (Denney et al.”
BackgroundPuangpetch, A., Suwannarat, P., Chamnanphol, M., Koomdee, N., Ngamsamut, N., Limsila, P., & Sukasem, C. (2015) · Disease Markers · doi:10.1155/2015/724935 · Cited by 25
Cytokines and etiopathogenesis of pervasive developmental disorders
Malek-Ahmadi, P. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1278 · Cited by 12
Long, J., Dang, H., Su, W., Moneruzzaman, M., & Zhang, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1370276 · Cited by 16
Pathogenesis of Autism: A Patchwork of Genetic Causes
Grigorenko, E. L. (2009) · Future Neurology · doi:10.2217/fnl.09.29 · Cited by 17
Singh, V. K. (2003) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4615-0323-1_16 · Cited by 15
“Based on these considerations, immune activation occurs naturally in autistic children because they have elevated levels of immune activation antigens such as sCD8, IL-2, IL-12 and IFN-y (28,30) and their blood contains activated T cells ( 28 ).”
BackgroundInfluentialSex‐specific association of a common variant of the XG gene with autism spectrum disorders
Chang, S., Pauls, D. L., Lange, C., Sasanfar, R., & Santangelo, S. L. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32165 · Cited by 21
“…but the structural similarity and sequence homology (48% homology of the amino acid sequence) between theXg andCD99molecules suggests that theymay share some similar immunological functions [Warren et al., 1986; Plioplys et al., 1994; Ellis et al., 1994a,b;Krause et al., 2002;Ashwood et al., 2003].”
BackgroundTamouza, R., Volt, F., Richard, J., Wu, C., Bouassida, J., Boukouaci, W., Lansiaux, P., Cappelli, B., Scigliuolo, G. M., Rafii, H., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.809686 · Cited by 12
Altered Immune Function In Autism
DelGiudice-Asch, G., & Hollander, E. (1997) · CNS Spectrums · doi:10.1017/s1092852900004909 · Cited by 11
“In a study of older autistic children, responses to PHA, con-A, and PWM were normal.(29) The explanation for these conflicting results remains unclear.”
ResultAn Immunologic Theory for the Development of Some Cases of Autism
Warren, R. P. (1998) · CNS Spectrums · doi:10.1017/s109285290000571x · Cited by 10
REHABILITATION OF AUTISM WITH IMMUNE MODULATION THERAPY
novini, I. I., Autizmot, R. N., IMUNO-MODULACISKA, S., Vijendra, T., Sing, K., & Singh, V. K. (2004) · doi:10.5281/zenodo.29031 · Cited by 9
Differential T Cell Levels of Tumor Necrosis Factor Receptor-II in Children With Autism
Ashwood, P. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00543 · Cited by 5
Rimland, B., & McGinnis, W. R. (2002) · Laboratory Medicine · doi:10.1093/labmed/33.9.708 · Cited by 5
RetractedHeuer, L. S., Ashwood, P., & de Water, J. V. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-489-0_12 · Cited by 9
“(IL-2R) [ 53 , 103, 104], dysregulated apoptosis mechanisms [46], and the imbalance of serum Ig levels [101, 105].”
BackgroundViruses and Psychiatric Disorders
Pearce, B. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-84851-8_18 · Cited by 4
“There is evidence for both an overactive and underactive immune system in autism spectrum disorders (Plioplys et al., 1994; van Gent et al., 1997; Korvatska et al., 2002; Pardo et al., 2005).”
BackgroundShaw, W., Baptist, J., Allergy Link, P. A., & Geenens, D. (2010) · North American Journal of Medicine and Science · doi:10.7156/v3i1p001 · Cited by 4
Trajkovski, V. (2015) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.29037 · Cited by 2
Immune Dysfunction in Autism Spectrum Disorders
Careaga, M., de Water, J. V., & Ashwood, P. (2012) · Molecular and integrative toxicology · doi:10.1007/978-1-61779-812-2_10 · Cited by 3
Sacco, R., Persico, A. M., Garbett, K. A., & Mirnics, K. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7197-5_18 · Cited by 3
Association of immune abnormalities with symptom severity in Egyptian autistic children
Raouf, H. A., Kholoussi, N. M., Kholoussi, S., Abo-Shanab, A. M., Ashaat, E. A., Ashaat, N. A., & Helwa, I. (2022) · Egyptian Pharmaceutical Journal · doi:10.4103/epj.epj_32_22 · Cited by 1
Autoimmunity in Autism Spectrum Disorders
Laila, Y. A. A. (2011) · InTech eBooks · doi:10.5772/17377 · Cited by 3
“Several immune abnormalities, suggestive of, dysregulated immune response reported in autistic children include incomplete or partial T cell activation evidenced by increased numbers of T cells without the expression of the -2 receptor (IL-2R) (Warren et al., 1986; Plioplys et al., 1994), dysregulated apoptosis mechan…”
InfluentialAmaral, D. G., Rubenstein, J. L. R., & Rogers, S. J. (2008) · Wiley eBooks · doi:10.1002/9780470515167.ch23 · Cited by 2
Edelson, S. B., & Cantor, D. S. (1998) · Toxicology and Industrial Health · doi:10.1177/074823379801400603 · Cited by 11
“During the last 40 years, autism has been described to be associated with many etiologies: phenylketonuria (3,7,8), histidinemia (9,10), heparin-n-sulfatase deficiency (11), tuberous sclerosis (12), fragile X syndrome (4,13), Rubella (14,15), Cytomegalic Virus (16,17), and a host of other possible risk factors ( 18-25…”
BackgroundNonhuman Primate Models for Autism Spectrum Disorders
Bauman, M. D., & Amaral, D. G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00027-2 · Cited by 3
Coexistence of type 1 diabetes mellitus, autism and blindness – narrative review and case report
CYRANKA, K. M., Dudek, D., Pilecki, M. W., Matejko, B., Krzyżowska, S., Malecki, M. T., & Klupa, T. (2022) · Archives of Psychiatry and Psychotherapy · doi:10.12740/app/154752
“[2, 19] showed that in 11 of 17 patients with autism had findings suggestive of “incomplete activation” of T-cells, a finding also seen in autoimmune diseases.”
Complementary Medicine Products Used in Autism - Evidence for Rationale
Semple, S. J., Hewton, C., Paterson, F., & Angley, M. T. (2011) · InTech eBooks · doi:10.5772/17357
“Autoantibodies against proteins associated with the central nervous system (CNS) has been reported in some children with autism (Singh et al. 1988; Plioplys et al. 1994; Vojdani et al. 2004).”
BackgroundAutism, Peripheral Immunity, and Polybrominated Diphenyl Ethers
Goines, P. E., Ashwood, P., & de Water, J. V. (2010) · Wiley eBooks · doi:10.1002/9780470917060.ch24
Gupta, S. (1999) · doi:10.1177/088307389901400314
Maternal Autoantibodies in Autism Spectrum Disorder
Jones, K. L., & de Water, J. V. (2014) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814602167_0017 · Cited by 1
Mott, M. C. (2011) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/1016
Burger (1998) · doi:10.1002/(sici)1098-2779(1998)4:2<137::aid-mrdd11>3.0.co;2-w
Metadata
- Authors
- Plioplys, A. V., Greaves, A., Kazemi, K., & Silverman, E.
- Affiliations
- Mercy Hospital and Medical Center (US)
- University of Toronto (CA)
- ORCID
- Silverman, E.
- Venue
- Neuropsychobiology
- Publisher
- S. Karger AG
- Published
- 2008-02-22
- Volume
- 29
- Issue
- 1
- Pages
- 12-16
- ISSN
- 0302-282X (ISSN-L)
- 1423-0224
- OpenAlex
- W2046642756
- Cited by
- 112
- References
- 0
- Citations by year
- 2024: 2 · 2022: 4 · 2020: 1 · 2018: 2 · 2016: 1 · 2015: 5 · 2014: 2 · 2013: 2 · 2012: 8
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Neuropsychobiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- autism spectrum disorder, Rett syndrome, lymphocyte function, CD4/CD8 ratio, activated T cells, HLA-DR, interleukin-2 receptor, T cell subsets, mitogen-induced proliferation, mixed lymphocyte reaction, autoimmune hypothesis, age-related changes
- MeSH terms
- Adolescent, Adult, Antigens, Surface, Autistic Disorder, B-Lymphocytes, Cell Division, Child, Female, Humans, Lymphocyte Activation, Lymphocytes, Male, Phenotype, T-Lymphocytes, Rett Syndrome, CD4-CD8 Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.